MYOV NYSE
Myovant Sciences Ltd.
1W: +0.1%
1M: +0.3%
3M: +0.3%
1Y: +137.1%
3Y: +173.6%
5Y: +68.6%
$26.98
Last traded 2023-03-09 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$379M
Revenue
+91.5% YoY
$-184M
Net Income
+19.4% YoY
$-271M
Free Cash Flow
-3.0% YoY
65.9%
Gross Margin
-51.8%
Op. Margin
-57.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE37.1%
ROA-36.5%
ROIC24.9%
Valuation
P/E-12.2
P/B-5.3
EV/EBITDA-19.3
Leverage
Debt/Equity-0.66
Current Ratio1.57
Interest Cov.-7.7x
Quality Scores
Piotroski F2/9
Altman Z-2.96
Beneish M-0.80